Home / 510(k) Clearances / K073558

510(k) K073558

SENSITITRE 18-24 SUSCEPTIBILITY PLATE by Trek Diagnostic Systems, Inc. — Product Code JWY

K073558 is an FDA 510(k) premarket notification submitted by Trek Diagnostic Systems, Inc. for the device "SENSITITRE 18-24 SUSCEPTIBILITY PLATE". The FDA issued a decision of Substantially Equivalent on Mar 13, 2008. The device falls under product code JWY (Manual Antimicrobial Susceptibility Test Systems), a Class II device regulated under 21 CFR 866.1640. Trek Diagnostic Systems, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 13, 2008
Date Received
Dec 19, 2007
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Manual Antimicrobial Susceptibility Test Systems
Device Class
Class II
Regulation Number
866.1640
Review Panel
MI
Submission Type

Other clearances by Trek Diagnostic Systems, Inc.

  • K133038 — SENSITITRE YEASTONE SUSCEPTIBILITY PLATES (Jan 31, 2014)
  • K112276 — VIZION (Nov 16, 2011)
  • K111615 — SENSITITRE 18-24 HR SUSCEPTIBILITY PLATES (Nov 8, 2011)
  • K110583 — SENSITITRE OPTIREAD (Sep 22, 2011)
  • K103532 — AUTOREADER 2 (Aug 26, 2011)
  • K111429 — SENSITITRE (R) HP MIC SUSCEPTIBILITY PLATE WITH CEFAROLINE (0.004-8UG/ML) AND TH (Aug 18, 2011)
  • K103456 — THE SENSITITRE AIM (Jun 22, 2011)
  • K110331 — SENSITITRE AIM (TM) (Apr 27, 2011)
  • K093741 — SENSITIVE HAEMOPHILUS INFLUENZAE, STREPTOCOCCUS PNEUMONIA, (HP) MIC SUSCEPTIBILI (Feb 25, 2010)
  • K093865 — SENSITITRE 18-24HR SUSCEPTIBILITY PLATES (Feb 17, 2010)

Other clearances for product code JWY

  • K260447 — ETEST Gepotidacin (GEP) (0.016-256 µg/mL) (Apr 21, 2026)
  • K260696 — MTS Gepotidacin 0.016-256 µg/mL (Apr 17, 2026)
  • K252114 — MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL (Oct 2, 2025)
  • K252062 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin (Sep 25, 2025)
  • K250575 — The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreon (Sep 5, 2025)
  • K252014 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin (Aug 28, 2025)
  • K251580 — MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD) (Aug 20, 2025)
  • K250990 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciproflox (Jun 30, 2025)
  • K242843 — The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) M (Jun 20, 2025)
  • K250856 — ETEST Aztreonam/Avibactam (AZA) (0.016/4-256/4 µg/mL) (Jun 12, 2025)

FDA data resources